Kestra Medical Technologies, Ltd. (KMTS)
NASDAQ: KMTS · Real-Time Price · USD
21.66
-0.57 (-2.56%)
Apr 28, 2026, 4:00 PM EDT - Market closed

Company Description

Kestra Medical Technologies, Ltd. operates as a wearable medical device and digital healthcare company.

It focuses on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected.

The company’s develops and commercializes Cardiac Recovery System platform, a system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution.

Its platform provides ASSURE WCD, a wearable cardioverter defibrillator used to protect patients at an elevated risk of sudden cardiac arrest; and a suite of integrated digital solutions and services that enable enhanced patient and provider engagement and oversight with the objective of improving patient outcomes.

The company was founded in 2014 and is based in Kirkland, Washington.

Kestra Medical Technologies, Ltd.
Kestra Medical Technologies logo
Country United States
Founded 2014
IPO Date Mar 6, 2025
Industry Medical Instruments & Supplies
Sector Healthcare
Employees 330
CEO Brian Webster

Contact Details

Address:
3933 Lake Washington Blvd NE, Suite 200
Kirkland, Washington 98033
United States
Phone 425 279 8002
Website kestramedical.com

Stock Details

Ticker Symbol KMTS
Exchange NASDAQ
Fiscal Year May - April
Reporting Currency USD
IPO Price $17.00
CIK Code 0001877184
CUSIP Number G52441105
ISIN Number BMG524411052
SIC Code 3841

Key Executives

Name Position
Brian Webster Founder, President, Chief Executive Officer and Director
Traci S. Umberger Co-Founder, General Counsel, Chief Administrative Officer, Secretary and Director
Vaseem Mahboob Chief Financial Officer
Gordon Teddy Chief Information Officer
Neil Bhalodkar Vice President of Investor Relations
Debra Schotz Senior Vice President of Marketing
Jeffrey Laub Senior Vice President of Operations
Phillip D. Foshee Jr. Senior Vice President of Research and Development
Alfred J. Ford Jr. Chief Commercial Officer
Timothy P. Moran Chief Business Officer

Latest SEC Filings

Date Type Title
Apr 15, 2026 144 Filing
Apr 8, 2026 SCHEDULE 13G/A Filing
Apr 1, 2026 S-3ASR Automatic shelf registration statement of securities of well-known seasoned issuers
Mar 18, 2026 S-8 Securities to be offered to employees in employee benefit plans
Mar 17, 2026 144 Filing
Mar 17, 2026 10-Q Quarterly Report
Mar 17, 2026 8-K Current Report
Feb 17, 2026 SCHEDULE 13G/A Filing
Feb 17, 2026 144 Filing
Feb 17, 2026 SCHEDULE 13G/A Filing